Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07294898 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight
A Phase 1 study, sponsored by Kailera.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT07294898 is a Phase 1 study that has completed, run by Kailera. The registered enrollment target is 18 participants.
The verdict
NCT07294898, a Phase 1 study, has completed, sponsored by Kailera.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
Interventions
- DRUG KAI-7535
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2026-01-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07294898
The ClinicalTrials.gov registry entry for NCT07294898 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kailera, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KAI-7535 is the first listed.
NCT07294898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07294898 about?
NCT07294898 is a clinical study titled "A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight". The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
What is the current status of trial NCT07294898?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2025-12-15. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT07294898?
The interventions under investigation include: KAI-7535 (DRUG).
Who is sponsoring clinical trial NCT07294898?
This trial is sponsored by Kailera, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.